CompletedPhase 2NCT00689182

Safety and Efficacy of Iron Reduction by Phlebotomy

Studying Rare hereditary hemochromatosis

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Andrea Kew
Principal Investigator: Andrea Kew, MD
Queen Elizabeth II Health Sciences Centre
Intervention: monthly phlebotomy x 12 months(procedure)
Enrollment: 23 target
Eligibility: 18-65 years · All sexes
Timeline: 2007 – 2012

Study locations (1)

QEII Health Sciences Centre, Halifax, Nova Scotia, Canada

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00689182 on ClinicalTrials.gov

Other trials for Rare hereditary hemochromatosis

Additional recruiting or active studies for the same condition.

RECRUITINGNCT05294471
Fully Automated High-Throughput Quantitative MRI of the Liver
University of Wisconsin, Madison

See all trials for Rare hereditary hemochromatosis →

← Back to all trials